Welcome to your daily briefing on healthcare developments in Delaware. Today we're covering 7 key stories including updates on delaware healthcare headlines, delaware healthcare updates, background & context. Let's dive in.
3 stories
The Delaware Division of Professional Regulation offers an online License Look-Up system through DELPROS for verifying professional credentials.
Healthcare professionals in DE can quickly verify licenses and credentials to ensure compliance, confirm colleague standing, or check practitioner status before referrals.
Delaware Health Force has made Delaware CMS provider data available through its website.
This dataset gives DE healthcare professionals direct access to Medicare and Medicaid provider information to support market analysis, network planning, and compliance work in the state.
The U.S. Department of Commerce has updated its resource guide for American exporters of healthcare technologies, equipment, and services targeting the German market.
DE healthcare professionals and industry stakeholders can leverage this guide to explore expansion opportunities and understand regulatory pathways for exporting medical innovations to one of Europe's largest healthcare markets.
Reach healthcare professionals
1 story
The Delaware State Medical Board provides a free online resource to verify medical licenses in the state.
DE healthcare professionals can quickly confirm credential status for themselves or colleagues without cost or hassle.
3 stories
The MIPS cost performance category is calculated retrospectively by CMS using attributed Medicare claims; clinicians cannot directly affect what is attributed. The two attribution methods (TPCC and MSPB) capture different beneficiary cohorts. Practices that try to "manage" cost without understanding which patients are attributed to which clinician typically waste effort.
Cost is now 30% of the MIPS final score — the largest single category. Misunderstanding attribution is the leading cause of unfavorable payment adjustments in the next cycle.
Covered entities must annually recertify their 340B eligibility through HRSA. Missing the recertification window pushes the entity to inactive status, which means immediate loss of 340B pricing and potentially diversion violations on previously dispensed drugs. Reinstatement requires a new application.
The discount value of 340B pricing for a covered entity often exceeds six figures annually. Letting the recertification lapse for paperwork reasons is one of the most expensive administrative errors in the regulation.
Across most payors, the top-five denial reasons account for over 80% of prior-auth rejections: missing clinical documentation, wrong CPT/HCPCS code, service not in benefit plan, step-therapy not completed, and ordering provider not on the patient's plan. The same five repeat across plans because they are the easiest to deny on automation.
Practices that build a five-line pre-submission checklist around these reasons typically cut prior-auth denials by 40-60% within a quarter. The fix is process, not appeals capacity.
Get Delaware healthcare intelligence delivered to your inbox every morning.
Subscribe FreeView all past issues
Feature your brand across the U.S., Canada, and select international markets and 10 industry verticals.
Become a National Partner